MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qai.0000000000003012

Медицинская библиотека · Journal of acquired immune deficiency syndromes (1999) · 2022

HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program.

Ndenkeh Jackson Jr Nforbewing, Bowring Anna L, Njindam Iliassou Mfochive, Folem Romeo Dongfack, Fako Guy Christian Hendji, Ngueguim Florent Gnintedem, Gayou Oscar Leyou, Lepawa Kelly, Minka Christine Minka, Batoum Christine Manyo, Georges Sandra, Temgoua Edith, Nzima Valery, Kob David Anouar, Akiy Zacheus Zeh, Philbrick William, Levitt Daniel, Curry Dora, Baral Stefan

СтатьяПоддержка NIH: внешняя программаПоддержка правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

Pre-exposure prophylaxis (PrEP) is proven to be a highly effective HIV prevention method for key populations. However, its scale-up in resource-limited settings remains suboptimal. This paper seeks to describe PrEP initiation and continuation among key populations in Cameroon.

METHODOLOGY: From June 2019 through October 2020, we collected routine program data on PrEP uptake and continuation among female sex workers (FSWs) and men who have sex with men (MSM) in the Continuum of prevention, care and treatment of HIV/AIDS with Most-at-risk Populations (CHAMP) program in Cameroon. PrEP was offered to clients who tested negative for HIV and were assessed to potentially benefit from PrEP. Using survival analysis, we identified factors associated with PrEP discontinuation over time with significance set at 5%.

RESULTS

Overall, 27,750 clients were sensitized for PrEP of whom 3,138 persons were eligible to start PrEP and 1,409 (45%; FSW: 691 and MSM: 718) initiated PrEP. The PrEP continuation rate was 37% at 3 months, 28% at 6 months and 19% at 12 months. PrEP discontinuation was significantly higher among FSW than MSM [adjusted hazard ratio (aHR) 1.5 (95% CI: 1.2 to 1.9)] in Yaounde [aHR 1.5 (95% CI: 1.2 to 1.9)] and Bafoussam/Bertoua [aHR 3.1 (2.2-4.5)] relative to Douala. Discontinuation was lower among those with moderate [aHR 0.3 (0.3-0.4)] or good adherence [aHR 0.4 (0.3-0.6)] compared with poor adherence (all P < 0.001).

CONCLUSION

Differentiated approaches to deliver PrEP, create demand, and provide more intensive support for adherence and continuation may support scale-up of PrEP in Cameroon for equitable and prolonged impact on HIV prevention.

Для цитирования: Ndenkeh Jackson Jr Nforbewing, Bowring Anna L, Njindam Iliassou Mfochive, Folem Romeo Dongfack, Fako Guy Christian Hendji, Ngueguim Florent Gnintedem, Gayou Oscar Leyou, Lepawa Kelly, Minka Christine Minka, Batoum Christine Manyo, Georges Sandra, Temgoua Edith, Nzima Valery, Kob David Anouar, Akiy Zacheus Zeh, Philbrick William, Levitt Daniel, Curry Dora, Baral Stefan. HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program.. Journal of acquired immune deficiency syndromes (1999). 2022. DOI: 10.1097/qai.0000000000003012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.